Upstream & Downstream Processing
thumbnail
Upstream & Downstream ProcessingBio-Techne Q2: CGT a ‘major growth driver’Bio-Techne Q2: CGT a ‘major growth driver’
Bio-Techne looks to the cell and gene therapy (CGT) sector to realign its financials, including the potential future acquisition of Wilson Wolf.